Oleg Nodelman
InvestorFounder + Portfolio Manager at EcoR1 Capital · Board director at Epikast · Board director at Aktis Oncology · Board director at Scorpion Therapeutics
San Francisco, California, United States
About
Founder and Portfolio Manager of EcoR1 Capital with over twenty years of biotech investing experience; previously a portfolio manager at BVF Partners and currently a board member of several publicly traded biotech companies. Holds a BS in Foreign Service from Georgetown University.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Epikast
Intro paths
→
In turn, Oleg can intro founders to Epikast's investors below.
Epikast's investors · 2
Board director at Aktis Oncology
Intro paths
→
In turn, Oleg can intro founders to Aktis Oncology's investors below.
Aktis Oncology's investors · 9
Andreessen HorowitzMenlo Park · $500K – $50M checks · since 2024EcoR1 CapitalSan Francisco · since 2024Janus Henderson InvestorsLondon · since 2024MPM BioImpactBoston · $1M – $15M checks · since 2024MRL Ventures FundCambridge · $25M checks · since 2024RA CapitalBoston · since 2024RTW Investments L.P.New York · since 2024TCG CrossoverPalo Alto · since 2024Vida VenturesLos Angeles · since 2024
Co-founders at Aktis Oncology
TF
Todd FoleyCo-founder and Chairman
PB
Patrick BaeuerleCo-founder & Advisor
Board director at Scorpion Therapeutics
Intro paths
→
In turn, Oleg can intro founders to Scorpion Therapeutics's investors below.
Scorpion Therapeutics's investors · 9
Atlas VentureCambridge · $500K – $1M checks · since 2024Avoro Capital AdvisorsNew YorkEcoR1 CapitalSan Francisco · since 2024Frazier Life SciencesPalo AltoLightspeed Venture PartnersMenlo Park · $1.7M – $87M checksNextech InvestZurich · $648K – $3.2M checksOlive Tree CapitalBostonOmega FundsBoston · since 2024Vida VenturesLos Angeles
Co-founders at Scorpion Therapeutics
AF
Adam FriedmanExecutive Officer, Director
GG
Gary GlickExecutive Officer, Director
Experience
- EcoR1 Capital, LLCFounder and Managing Directorcurrent2012 — presentSan Francisco Bay Area
- The Gladstone InstitutesPresident's Council2012 — 2015San Francisco Bay Area
- Kindred BioNon Executive Director2013 — 2014San Francisco Bay Area
- Addex PharmaceuticalsNon-Executive Director2011 — 2014Geneva, Geneva, Switzerland
- BVF Partners LPPortfolio Manager2001 — 2012San Francisco Bay Area
- Mercer Management ConsultingConsultant1999 — 2001San Francisco Bay Area
- Atlanta Olympic BroadcastingRussian Translator1996Atlanta Metropolitan Area
Skills & more
Mergers & AcquisitionsDue DiligenceVenture CapitalBiotechnologyInvestmentsBusiness StrategyPortfolio ManagementValuationMergersBusiness DevelopmentInvestment BankingStart-ups
+12 more
Hedge FundsExecutive ManagementPrivate EquityRisk ManagementCorporate DevelopmentFinancial AnalysisLife SciencesFinanceStrategyPharmaceutical IndustryManagementFinancial ModelingLanguages French · Russian · Spanish
From Oleg's professional profile.
Deals · 2
Aktis OncologyBoard seat
via EcoR1 Capital · filed Oct 2024 · $175M raise
Scorpion TherapeuticsBoard seat
via EcoR1 Capital · filed Jul 2024 · $150M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
AnaptysBioEpikastLakefront BiotherapeuticsReCode TherapeuticsZymeworks
Sources: SEC Form D filings · the firm's website.
Colleagues at EcoR1 Capital
Areesha Saif
Analyst at EcoR1 Capital
Basheer Zada
Principal at EcoR1 Capital
Caroline Cho
Executive Personal Assistant at EcoR1 Capital
Caroline Stout
Partner at EcoR1 Capital
Catherine McWilliams
Director of Partner Relations at EcoR1 Capital
Daniel Rodriguez
Counsel at EcoR1 Capital
Geoff Keough
Trader at EcoR1 Capital
Maddie Gehrich
Investor Relations Associate at EcoR1 Capital
Frequently asked questions
- Who is Oleg Nodelman?
- Founder and Portfolio Manager of EcoR1 Capital with over twenty years of biotech investing experience; previously a portfolio manager at BVF Partners and currently a board member of several publicly traded biotech companies. Holds a BS in Foreign Service from Georgetown University.
- Where does Oleg Nodelman work?
- Oleg Nodelman is Founder + Portfolio Manager at EcoR1 Capital and Board director at Epikast and Board director at Aktis Oncology and Board director at Scorpion Therapeutics.
- What does Oleg Nodelman invest in?
- Oleg Nodelman invests in Biotech.
- What boards does Oleg Nodelman sit on?
- Oleg Nodelman holds tracked board seats at Aktis Oncology, AnaptysBio, Epikast, Lakefront Biotherapeutics, ReCode Therapeutics, Scorpion Therapeutics, Zymeworks.
- Where did Oleg Nodelman go to school?
- Oleg Nodelman studied at Georgetown University (BSFS, Foreign Service / Science and Technology).
Same school
Also attended Georgetown University528
Trae StephensPartner at Founders Fund and co-founder of AndurilLuciana LixandruPartner at Sequoia CapitalKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Tobi CokerDeal Partner at Felicis VenturesAna AndreescuInvestor at Index VenturesThanachat Tangsriwongタイオフィス代表 (Thailand Office Representative) at CyberAgent Capital
+ 522 more
Shared employers
Also worked at EcoR1 Capital, LLC12
Sarah MarriottPartner and COO at EcoR1 CapitalScott PerlenCFO at EcoR1 CapitalCaroline StoutPartner at EcoR1 CapitalWhan LeeAnalyst at EcoR1 CapitalBasheer ZadaPrincipal at EcoR1 CapitalAreesha SaifAnalyst at EcoR1 Capital
+ 6 more
Also worked at The Gladstone Institutes7
Deep NisharInvestment Team at General CatalystYvanka de SoysaAssociate at Foreground CapitalRamit NagpalVice President and General Counsel, Legal, Institutional Risk and Governance at International Finance CorporationMinnie SarwalVenture Advisor at Pier 70 VenturesZak DoricPartner at Andreessen HorowitzMichael PennFounding Partner at Health Equity Ventures
+ 1 more
